Search Results By Date:
Showing 346 - 360 of 608 results
  • Onitilo AA, Engel JM. Managing relapse of CML using therapeutic imatinib plasma level. Clin Adv Hematol Oncol. 2009 November; 7(11):763-7.
    PubMed ID: 20075835
  • Purdue M, Lan Q, Martinez-Maza O, Oken MM, Hocking WG, Huang WY,...Rothman N. (2009 September). A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma. BLOOD. 114(13):2730-2.
    PubMed ID: 19540395
  • Mirabello L, Huang WY, Wong JY, Chatterjee N, Reding DJ, David Crawford E,...Savage SA. (2009 August). The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell. 8(4):405-13.
    PubMed ID: 19493248
  • Gupta AK, Pinsky P, Rall CJ, Mutch M, Dry SM, Seligson D, Schoen RE. (2009 August). Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci. Gastrointest Endosc. 70(2):322-30.
    PubMed ID: 19539919
  • Ruder AM, Carreon T, Butler MAnn, Calvert GM, Davis-King KE, Waters MA,...The Brain Cancer Collaborative Study Group. [including Reding DJ.] (2009 June). Exposure to farm crops, livestock, and farm tasks and risk of glioma: the Upper Midwest Health Study. Am J Epidemiol. 169(12):1479-91.
    PubMed ID: 19403843
  • Onitilo AA, Engel JM, Greenlee RT, Mukesh BNanjan. (2009 June). Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival. Clin Med Res. 7(1-2):4-13.
    PubMed ID: 19251585
  • Doi SA. R., Onitilo AA. (2009 June). Author Reply Clinical Medicine & Research. 7(1-2):2-3.
  • Onitilo AA, Wilke RA, Glurich IE, Engel JM, Flockhart DA, Nguyen A,...Gin Y. Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. BREAST CANCER RESEARCH AND TREATMENT. 2009 June; 115(3):643-50.
    PubMed ID: 19082882
  • Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res. 2009 June; 7(1-2):4-13. PMCID: PMC2705275.
    PubMed ID: 19574486
  • Croswell JMiller, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SB,...Schoen RE [including Reding DJ.] (2009 May). Cumulative incidence of false-positive results in repeated, multimodal cancer screening. ANNALS OF FAMILY MEDICINE. 7(3):212-22.
    PubMed ID: 19433838
  • Mutch M, Schoen RE, Fleshman J, Rall CJ, Dry S, Seligson D,...Pinsky PF. (2009 May). A multicenter study of prevalence and risk factors for aberrant crypt foci Clinical Gastroenterology and Hepatology. 7(5):568-74.
    PubMed ID: 19418605
  • Schenk JM, Riboli E, Chatterjee N, Leitzmann MF, Ahn J, Albanes D,...Peters U [including Reding DJ.] (2009 April). Serum Retinol and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev. 18(4):1227-31.
    PubMed ID: 19336558
  • Lee KM, Kang D, Park SK, Berndt SI, Reding DJ, Chatterjee N,...Hayes RB. (2009 April). Nitric oxide synthase gene polymorphisms and prostate cancer risk. CARCINOGENESIS. 30(4):621-5.
    PubMed ID: 19168583
  • Onitilo AA, Engel JM, Lundgren CIhre, Hall P, Thalib L, Doi SA. R.. Simplifying the TNM system for clinical use in differentiated thyroid cancer. JOURNAL OF CLINICAL ONCOLOGY. 2009 April; 27(11):1872-8.
    PubMed ID: 19273697
  • Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR,...PLCO Project Team [including Reding DJ.] (2009 March). Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 3(13):1310-19.
    PubMed ID: 19297565